Imaging of secretory tumors of the gastrointestinal tract

[1]  王炳煌.  Insulinoma , 2004, Concise Notes in Oncology for MRCP and MRCS.

[2]  J. Smirniotopoulos,et al.  Multiple Endocrine Neoplasia, Type 1: Imaging Solutions to Clinical Questions. , 2016, Current problems in diagnostic radiology.

[3]  V. Prasad,et al.  Diagnostic imaging of pancreatic neuroendocrine neoplasms (pNEN): tumor detection, staging, prognosis, and response to treatment , 2016, Acta radiologica.

[4]  G. Poultsides,et al.  Non-functional neuroendocrine tumors of the pancreas: Advances in diagnosis and management. , 2015, World journal of gastroenterology.

[5]  A. Grossman,et al.  Neurofibromatosis Type 1 and pancreatic islet cell tumours: an association which should be recognized. , 2015, QJM : monthly journal of the Association of Physicians.

[6]  Peter D. Poullos,et al.  Pancreatic neuroendocrine tumours: hypoenhancement on arterial phase computed tomography predicts biological aggressiveness. , 2014, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[7]  S. Kapoor.  Mckittrick–Wheelock syndrome: an often, overlooked complication of rectal adenomas , 2014, Surgical Endoscopy.

[8]  D. Sahani,et al.  Gastroenteropancreatic neuroendocrine tumors: role of imaging in diagnosis and management. , 2013, Radiology.

[9]  R. Vikram,et al.  Pancreatic neuroendocrine neoplasms: diagnosis and management , 2013, Abdominal Imaging.

[10]  A. Faggiano,et al.  Epidemiology of gastroenteropancreatic neuroendocrine tumours. , 2012, Best practice & research. Clinical gastroenterology.

[11]  M. Harisinghani,et al.  Pancreatic neuroendocrine tumors in patients with tuberous sclerosis complex , 2012, Clinical genetics.

[12]  Walter G. Park,et al.  Pancreatic Neuroendocrine Tumors: Radiographic Calcifications Correlate with Grade and Metastasis , 2012, Annals of Surgical Oncology.

[13]  R. Hicks,et al.  High management impact of Ga‐68 DOTATATE (GaTate) PET/CT for imaging neuroendocrine and other somatostatin expressing tumours , 2012, Journal of medical imaging and radiation oncology.

[14]  M. Herrera,et al.  Pancreatic incidentalomas. , 2012, Best practice & research. Clinical endocrinology & metabolism.

[15]  G. Klöppel.  Classification and pathology of gastroenteropancreatic neuroendocrine neoplasms. , 2011, Endocrine-related cancer.

[16]  James E. Huprich,et al.  CT-Enterography May Identify Small Bowel Tumors Not Detected by Capsule Endoscopy: Eight Years Experience at Mayo Clinic Rochester , 2011, Digestive Diseases and Sciences.

[17]  Ben Lawrence,et al.  The epidemiology of gastroenteropancreatic neuroendocrine tumors. , 2011, Endocrinology and metabolism clinics of North America.

[18]  C. Menias,et al.  Imaging of Carcinoid Tumors: Spectrum of Findings With Pathologic and Clinical Correlation , 2011, Journal of computer assisted tomography.

[19]  M. Coleman,et al.  Carcinoid Tumors of the Gastrointestinal Tract: Trends in Incidence in England Since 1971 , 2010, The American Journal of Gastroenterology.

[20]  B. Niederle,et al.  Gastroenteropancreatic neuroendocrine tumours: the current incidence and staging based on the WHO and European Neuroendocrine Tumour Society classification: an analysis based on prospectively collected parameters. , 2010, Endocrine-related cancer.

[21]  E. Paal,et al.  Pancreatic endocrine tumors: radiologic-clinicopathologic correlation. , 2010, Radiographics : a review publication of the Radiological Society of North America, Inc.

[22]  R. Jensen,et al.  NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas. , 2010, Pancreas.

[23]  M. Falconi,et al.  Clinicopathological Features of Pancreatic Endocrine Tumors: A Prospective Multicenter Study in Italy of 297 Sporadic Cases , 2010, The American Journal of Gastroenterology.

[24]  E. Araki,et al.  A case of ectopic adrenocorticotropic hormone-producing pancreatic neuroendocrine tumor with multiple liver metastases. , 2010, Endocrine journal.

[25]  L. Miles,et al.  Giant villous adenoma presenting as McKittrick–Wheelock syndrome and pseudo‐obstruction , 2010, The Medical journal of Australia.

[26]  C. Yeo,et al.  Periampullary and Duodenal Neoplasms in Neurofibromatosis Type 1: Two Cases and an Updated 20-Year Review of the Literature Yielding 76 Cases , 2010, Journal of Gastrointestinal Surgery.

[27]  H. Pitt,et al.  Small Pancreatic and Periampullary Neuroendocrine Tumors: Resect or Enucleate? , 2009, Journal of Gastrointestinal Surgery.

[28]  S. Yamada,et al.  Nonfunctioning neuroendocrine pancreatic tumors: our experience and management. , 2009, Journal of hepato-biliary-pancreatic surgery.

[29]  Quan P. Ly,et al.  Management of the primary tumor in patients with metastatic pancreatic neuroendocrine tumor: a contemporary single-institution review. , 2009, American journal of surgery.

[30]  S. Giustini,et al.  Gastrointestinal and Retroperitoneal Manifestations of Type 1 Neurofibromatosis , 2009, Journal of Gastrointestinal Surgery.

[31]  G. Kaltsas,et al.  ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Radiological Examinations , 2008, Neuroendocrinology.

[32]  M. Papotti,et al.  ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Towards a Standardized Approach to the Diagnosis of Gastroenteropancreatic Neuroendocrine Tumors and Their Prognostic Stratification , 2008, Neuroendocrinology.

[33]  I. Drozdov,et al.  Neuroendocrine tumor epidemiology , 2008, Cancer.

[34]  D. Metz,et al.  Gastrointestinal neuroendocrine tumors: pancreatic endocrine tumors. , 2008, Gastroenterology.

[35]  D. Bingham,et al.  Inherited pancreatic endocrine tumor syndromes: Advances in molecular pathogenesis, diagnosis, management, and controversies , 2008, Cancer.

[36]  L. Fernández‐Cruz,et al.  Is Laparoscopic Resection Adequate in Patients with Neuroendocrine Pancreatic Tumors? , 2008, World Journal of Surgery.

[37]  R. Jensen,et al.  Gastroenteropancreatic neuroendocrine tumours. , 2008, The Lancet. Oncology.

[38]  K. Campbell,et al.  Acinar Cell Carcinoma of the Pancreas: An Institutional Series of Resected Patients and Review of the Current Literature , 2008, Journal of Gastrointestinal Surgery.

[39]  J. Cameron,et al.  Pancreatic VIPomas: Subject Review and One Institutional Experience , 2008, Journal of Gastrointestinal Surgery.

[40]  Po-Huang Lee,et al.  Is Surgery Indicated for Patients with Symptomatic Nonfunctioning Pancreatic Neuroendocrine Tumor and Unresectable Hepatic Metastases? , 2007, World Journal of Surgery.

[41]  S. Nguyen,et al.  Surgery in malignant pancreatic neuroendocrine tumors , 2007, Journal of surgical oncology.

[42]  R. Bale,et al.  68Ga-DOTA-Tyr3-Octreotide PET in Neuroendocrine Tumors: Comparison with Somatostatin Receptor Scintigraphy and CT , 2007, Journal of Nuclear Medicine.

[43]  G. Åkerström,et al.  Surgery on neuroendocrine tumours. , 2007, Best practice & research. Clinical endocrinology & metabolism.

[44]  J. Izbicki,et al.  Aggressive Surgery Improves Long-term Survival in Neuroendocrine Pancreatic Tumors: An Institutional Experience , 2007, Annals of surgery.

[45]  H. Pitt,et al.  Surgical experience with pancreatic and peripancreatic neuroendocrine tumors: Review of 125 patients , 1998, Journal of Gastrointestinal Surgery.

[46]  L. Sobin,et al.  From the archives of the AFIP: Gastrointestinal carcinoids: imaging features with clinicopathologic comparison. , 2007, Radiographics : a review publication of the Radiological Society of North America, Inc.

[47]  T. Fahey.  Serum Gastrin in Zollinger-Ellison Syndrome I. Prospective Study of Fasting Serum Gastrin in 309 Patients From the National Institutes of Health and Comparison With 2229 Cases From the Literature , 2007 .

[48]  M. Kanematsu,et al.  Pancreas: optimal scan delay for contrast-enhanced multi-detector row CT. , 2006, Radiology.

[49]  L. Sobin,et al.  Brunner's gland hyperplasia and hamartoma: imaging features with clinicopathologic correlation. , 2006, AJR. American journal of roentgenology.

[50]  F. Gleeson,et al.  Multiple endocrine neoplasia: spectrum of radiologic appearances and discussion of a multitechnique imaging approach. , 2006, Radiographics : a review publication of the Radiological Society of North America, Inc.

[51]  K. Horton,et al.  Multi-detector row CT of pancreatic islet cell tumors. , 2006, Radiographics : a review publication of the Radiological Society of North America, Inc.

[52]  L. Sobin,et al.  Duodenal carcinoids: imaging features with clinical-pathologic comparison. , 2005, Radiology.

[53]  B. Eriksson,et al.  Endocrine tumours of the pancreas. , 2005, Best practice & research. Clinical gastroenterology.

[54]  G. Nikou,et al.  VIPomas: an update in diagnosis and management in a series of 11 patients. , 2005, Hepato-gastroenterology.

[55]  Amy K Hara,et al.  Imaging of small bowel disease: comparison of capsule endoscopy, standard endoscopy, barium examination, and CT. , 2005, Radiographics : a review publication of the Radiological Society of North America, Inc.

[56]  S. Silverman,et al.  CT and MRI features of pure acinar cell carcinoma of the pancreas in adults. , 2005, AJR. American journal of roentgenology.

[57]  T. de Baère,et al.  Detection of liver metastases from endocrine tumors: a prospective comparison of somatostatin receptor scintigraphy, computed tomography, and magnetic resonance imaging. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[58]  A. V. van Beek,et al.  The glucagonoma syndrome and necrolytic migratory erythema: a clinical review. , 2004, European journal of endocrinology.

[59]  Herb Chen,et al.  Pancreatic endocrine tumors. , 2004, The Journal of surgical research.

[60]  J. Norton,et al.  Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors. , 2003, Archives of surgery.

[61]  I. Modlin,et al.  A 5‐decade analysis of 13,715 carcinoid tumors , 2003, Cancer.

[62]  L. Sobin,et al.  Carcinoid Tumor of the Esophagus: A Clinicopathologic Study of Four Cases , 2002, The American journal of surgical pathology.

[63]  J. Norton,et al.  Intraoperative ultrasound and preoperative localization detects all occult insulinomas; discussion 1025-6. , 2001, Archives of surgery.

[64]  N. Ordóñez.  Pancreatic Acinar Cell Carcinoma , 2001, Advances in anatomic pathology.

[65]  P. Ruszniewski,et al.  Prognostic Factors in Patients With Zollinger-Ellison Syndrome and Multiple Endocrine Neoplasia Type 1 , 1999 .

[66]  G. Lindberg,et al.  Atypical carcinoid of the esophagus , 1997, Cancer.

[67]  D. Metz,et al.  Determinants of metastatic rate and survival in patients with Zollinger-Ellison syndrome: a prospective long-term study. , 1995, Gastroenterology.

[68]  C. Bordi.  Endocrine tumours of the stomach. , 1995, Pathology, research and practice.

[69]  D. Hough,et al.  Pancreatic lesions in von Hippel-Lindau disease: prevalence, clinical significance, and CT findings. , 1994, AJR. American journal of roentgenology.

[70]  J. Norton,et al.  Adrenocorticotropic hormone--secreting islet cell tumors: are they always malignant? , 1994, Radiology.

[71]  H. Brambs,et al.  Pancreatic lesions in the von Hippel-Lindau syndrome. , 1991, Gastroenterology.

[72]  J. Feldman.  Carcinoid tumors and syndrome. , 1987, Seminars in oncology.

[73]  J. Coombs,et al.  Metastatic islet cell tumor in von Hippel-Lindau disease. , 1984, The American journal of medicine.

[74]  T. Berge,et al.  Carcinoid tumours. Frequency in a defined population during a 12-year period. , 2009, Acta pathologica et microbiologica Scandinavica. Section A, Pathology.

[75]  K. Melmon,et al.  Lindau's disease: Review of the literature and study of a large kindred , 1964 .